Space Health institute selects new research studies to safeguard human health during deep space exploration
The Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine has selected six new biomedical research projects for space applications to receive two years of funding.
These projects aim to develop novel solutions to some of NASA’s highest priority risks to human health and performance during deep space exploration missions.
The Institute is proud to fund this group of innovators working to support human health for deep space exploration,” said Dr. Dorit Donoviel, Director of the Translational Research Institute for Space Health at Baylor College of Medicine. “This work moves us all closer to the day we will send human to Mars.”
Topic areas include imaging in the eye as a means of assessing overall health; physical health surveillance of astronauts on deep space missions; augmented medical knowledge and guidance on deep space missions; and “just in time” medications.
During their two years of funding, awardees will be tasked with delivering groundbreaking investigative research in these areas to protect astronaut health in deep space.
More information on the selections, including the names of the awardees, can be found at: https://www.nasa.gov/feature/
As a partner to NASA’s Human Research Program, TRISH helps solve the health challenges to human deep space exploration. The Institute finds and funds disruptive, breakthrough research and technologies that can reduce risks to astronaut health and performance.
The Institute is funded through a cooperative agreement with NASA to Baylor College of Medicine and includes consortium partners Caltech and Massachusetts Institute of Technology.
Sign up online to be notified of future TRISH solicitation announcements.
